Literature DB >> 23635925

Visual system involvement in CADASIL.

Elena Pretegiani1, Francesca Rosini, Maria T Dotti, Silvia Bianchi, Antonio Federico, Alessandra Rufa.   

Abstract

BACKGROUND AND
OBJECTIVE: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary arteriolar small-vessel disease caused by Notch3 mutations. A detailed definition of the neuro-ophthalmologic spectrum of CADASIL might provide new insights in the pathophysiology of small-vessel diseases. Therefore, this study aims to precisely delineate the features and the prevalence of the visual system impairment in CADASIL.
METHODS: A cohort of 34 genetically confirmed CADASIL patients was enrolled in an observational cross-sectional study. Subjects underwent a complete neuro-ophthalmological evaluation. Clinical features and common cardiovascular risk factors were also considered. Data were compared with those already reported in previous studies.
RESULTS: Both afferent and efferent visual structures were commonly impaired in CADASIL patients. Retinal microvascular changes such as arteriolar narrowing and arteriovenous nicking, described in most patients and detected also in asymptomatic carriers, reflect the typical hemodynamic changes of CADASIL. However, less frequent findings, like early macular and lens changes, would indicate a possible further role played by susceptibility to premature aging and degeneration. Cotton wool spots and vessel occlusions were not common. Finally, eye movement abnormalities suggest that the brainstem is particularly vulnerable to damage in CADASIL.
CONCLUSIONS: Although no specific or prominent neuro-ophthalmologic finding can be considered as hallmark of the disease, afferent and efferent visual system abnormalities could be accounted as complementary markers to study cerebral small-vessel diseases.
Copyright © 2013 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CADASIL; neuro-ophthalmology; retinal vessels; small-vessel disease

Mesh:

Substances:

Year:  2013        PMID: 23635925     DOI: 10.1016/j.jstrokecerebrovasdis.2013.03.032

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  6 in total

1.  The association between retinal nerve fibre layer thickness and corpus callosum index in different clinical subtypes of multiple sclerosis.

Authors:  Vedat Cilingir; Muhammed Batur; Mehmet Deniz Bulut; Aysel Milanlioglu; Abdullah Yılgor; Abdussamet Batur; Tekin Yasar; Temel Tombul
Journal:  Neurol Sci       Date:  2017-04-10       Impact factor: 3.307

2.  Multimodal retinal vessel analysis in CADASIL patients.

Authors:  Florian Alten; Jeremias Motte; Carina Ewering; Nani Osada; Christoph R Clemens; Ella M Kadas; Nicole Eter; Friedemann Paul; Martin Marziniak
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

Review 3.  Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects.

Authors:  Ilaria Di Donato; Silvia Bianchi; Nicola De Stefano; Martin Dichgans; Maria Teresa Dotti; Marco Duering; Eric Jouvent; Amos D Korczyn; Saskia A J Lesnik-Oberstein; Alessandro Malandrini; Hugh S Markus; Leonardo Pantoni; Silvana Penco; Alessandra Rufa; Osman Sinanović; Dragan Stojanov; Antonio Federico
Journal:  BMC Med       Date:  2017-02-24       Impact factor: 8.775

Review 4.  Retinal Vascular Imaging in Vascular Cognitive Impairment: Current and Future Perspectives.

Authors:  Oana M Dumitrascu; Touseef A Qureshi
Journal:  J Exp Neurosci       Date:  2018-09-20

5.  Retinal biomarkers of Cerebral Small Vessel Disease: A systematic review.

Authors:  Elena Biffi; Zachary Turple; Jessica Chung; Alessandro Biffi
Journal:  PLoS One       Date:  2022-04-14       Impact factor: 3.240

6.  Protection of the brain through supplementation with larch arabinogalactan in a rat model of vascular dementia.

Authors:  Sun Ha Lim; Jongwon Lee
Journal:  Nutr Res Pract       Date:  2017-09-28       Impact factor: 1.926

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.